Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lumpy skin disease inactivated vaccine
- Development stage
- Unknown
- Lead developer
- Shenlian Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The bovine lumpy skin disease vaccine developed by Shen Lian Biotech is an inactivated vaccine designed for the prevention of Lumpy Skin Disease (LSD) in cattle. It utilizes an inactivated goatpox virus strain (SGP-01) which provides cross-protective immunity against the Lumpy Skin Disease Virus (LSDV), a closely related capripoxvirus. By inducing a robust immune response, the vaccine protects cattle from the fever and skin nodules characteristic of LSD. It was the first inactivated vaccine for this indication to receive approval in China, offering a safe alternative to live-attenuated vaccines in the management of LSD outbreaks. The vaccine is administered via intramuscular injection and is intended to enhance livestock biosecurity in regions where LSD is endemic or emerging.
- Other names
- 牛结节性皮肤病灭活疫苗Lumpy Skin Disease Inactivated VaccineLSD inactivated vaccine
Beyond the preview
Go deeper on lumpy skin disease inactivated vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lumpy skin disease inactivated vaccine.